Sun Pharmaceutical Industries Q4 Results
- BSE: 524715
- NSE: SUNPHARMA
- ISIN: INE044A01036
- Sector: Biotechnology & Drugs
BSE
1,804.65
6.85 (0.38%)
6.85 (0.38%)Volume27.81 K
Updated: Mon 25 Nov, 2024 | 15:48:46
NSE
1,81014.70 (0.82%)
14.70 (0.82%)Volume3.14 M
Updated: Mon 25 Nov, 2024 | 15:29:59
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Sun Pharmaceutical Industries Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 24 | Dec 22 | QoQ Comp | Mar 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 11,982.90 | 11,240.97 | -% | 10,930.67 | -% |
| Selling/ General/ Admin Expenses Total | 2,299.34 | 2,037.07 | -% | 2,179.55 | -% |
| Depreciation/ Amortization | 650.36 | 659.95 | -% | 671.53 | -% |
| Other Operating Expenses Total | 4,211.62 | 3,393.38 | -% | 3,671.60 | -% |
| Total Operating Expense | 9,643.37 | 8,894.07 | -% | 8,944.35 | -% |
| Operating Income | 2,339.53 | 2,346.90 | -% | 1,986.32 | -% |
| Net Income Before Taxes | 2,815.52 | 2,471.47 | -% | 2,239.69 | -% |
| Net Income | 2,654.58 | 2,166.01 | -% | 1,984.47 | -% |
| Diluted Normalized EPS | 11.50 | 9.00 | -% | 8.96 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST